Goldman Sachs Russias Crude Exports Hold Steady Despite US Sanctions Oil Edges Lower Rising Private Credit Defaults Pose Challenges for Banks and Insurers Nvidia Plunges 16 as US Tech Stocks Tumble on China AI Fears SEC Delays Regulatory Exemptions for Tokenized Stock Trading Major Tech Firms Establish 125 Million Semiconductor Research Hub at UCLA Sun Pharma Reports 26 Net Profit Growth in Q4 Driven by Strong Sales and Strategic Investments FTAIM Q1 2026 Earnings Preferred Shares Steady as EPS Falls Short of Estimates TrioTech International TRT Q3 2024 Earnings Modest Profit Reported Amidst Challenging Environment PEB Q1 2026 Earnings EPS Exceeds Estimates as Hotel REIT Navigates Challenging Environment Bed Bath Beyond Inc BBBY Q1 2026 Earnings NarrowerthanExpected Loss Reported Amid Restructuring Uncertainty BlackRock BLK Q1 2026 Earnings EPS Beat Drives Modest Stock Gain PXLW Q1 2026 Earnings Massive EPS Surprise of 8825 as Company Reports 1246 vs 014 Estimate ProCap Financial Inc Warrant BRRWW Declines 26 as Warrants Trade Near Critical Support Levels Eaton Vance Global Dividend Opp ETO Edges Higher as Income Seekers Return Bluerock Homes Trust BHM Edges Higher Navigating Support and Resistance at 1062 Telesat Corporation TSAT Shows Resilience with Slight Uptick Testing Key Levels Orchid Island Capital ORC Edges Higher Approaches Key Resistance at 727 Love Factually Dating Startups Deploy Novel Approaches to Combat Fake Profiles Treasury Yield Surge Challenges RiskFree Asset Assumptions as Geopolitical Tensions and Inflation Reshape Fed Policy Outlook Tulsi Gabbard Resigns as US National Intelligence Director Citing Husbands Illness US Gasoline Demand Expected to Rise as Summer Travel Season Begins Potentially Adding Price Pressure Analysts Suggest MegaIPOs from SpaceX and OpenAI Could Indicate Market Peak Autodesk Q1 Earnings Preview Market Awaits Key Metrics and Guidance General Motors Introduces AllElectric Cadillac Vistiq with Over 300Mile Range SMR Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage Stock Barely Moves KalVista Pharmaceuticals KALV Holds Steady Near Support as Biotech Sector Watches for Catalyst